Scholars@Duke
William Schuyler Jones

William Schuyler Jones

Professor of Medicine
Medicine, Cardiology
schuyler.jones@duke.edu
Duke Box 3330, Durham, NC 27710
2400 Pratt Street, 7037, Durham, NC 27705

Scholarly Works - Conferences

Predictors and outcomes of intracranial hemorrhage in 58,000 patients with atrial fibrillation on oral anticoagulation: insights from COMBINE-AF

Conference European Heart Journal · October 28, 2024 AbstractBackgroundAmong anticoagulated patients with atrial fibrillation (AF), intracranial hemorrhage (ICH) is the leading cause of b ... Full text Cite

Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry.

Conference J Soc Cardiovasc Angiogr Interv · February 2024 BACKGROUND: Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor before coronary angiography. METHODS: Cangrelor in Acute MI: Effectiveness and Outcomes ... Full text Link to item Cite

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.

Conference Circulation · December 12, 2023 BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgi ... Full text Link to item Cite

Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes.

Conference Am J Prev Cardiol · June 2023 OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice. The objective of this analysis was to determine how Lp(a) testing is used in clin ... Full text Link to item Cite

TRENDS AND OUTCOMES IN AORTIC STENOSIS COMPLICATED BY SHOCK

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 7, 2023 Link to item Cite

CLASSIFICATION AND IMPLICATIONS OF HEART FAILURE EVENTS FROM THE VICTORIA TRIAL

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 8, 2022 Link to item Cite

RISK PROFILE AND LONG-TERM PROGNOSIS OF PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 24, 2020 Link to item Cite

LAWN MOWER VS. LEFT VENTRICULAR ASSIST DEVICE: A CASE OF TRAUMATIC CORONARY INJURY

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 24, 2020 Link to item Cite

First-in-human experience with Aortix intraaortic pump.

Conference Catheter Cardiovasc Interv · February 15, 2019 BACKGROUND: There are limited options for percutaneous mechanical circulatory support (pMCS) in patients requiring high-risk percutaneous coronary intervention. OBJECTIVES: This first-in-human, single-center study aimed to evaluate the safety and feasibili ... Full text Link to item Cite

ELECTRONIC HEALTH RECORD ALGORITHMS TO DETECT PAD

Conference Journal of the American College of Cardiology · March 2018 Full text Cite

MAJOR BLEEDING IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE EUCLID TRIAL

Conference Journal of the American College of Cardiology · March 2018 Full text Cite

Peripheral Artery Disease and Cardiovascular Risk in Patients Presenting With Chest Pain: Insights From the PROMISE Trial

Conference · 2017 Introduction: Peripheral artery disease (PAD) is considered a coronary risk equivalent and is associated with increased risk of adverse cardiovascular (CV) events. Yet, as compared to other high-risk groups, little is known about the relative risk of adver ... Cite

Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.

Conference Circulation · November 11, 2014 BACKGROUND: Tremendous advances have occurred in therapies for peripheral vascular disease (PVD); until recently, however, it has not been possible to examine the entire clinical trial portfolio of studies for the treatment of PVD (both arterial and venous ... Full text Link to item Cite

Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry.

Conference J Am Coll Cardiol · July 2, 2013 OBJECTIVES: The aim of this paper was to examine disparities in the use of cardioprotective medications in the treatment of peripheral artery disease (PAD) by socioeconomic status (SES). BACKGROUND: PAD is associated with increased cardiovascular risk and ... Full text Link to item Cite